Clinical trial
Observational Study of the Efficacy, Safety and Tolerance of Travogen Cream (Isoconazole) and Travocort Cream (Isoconazole, Diflurcortolone) in the Treatment of Patients With Local Skin Mycosis of Various Etiology and Localization
NCT00722189 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study of the Efficacy, Safety and Tolerance of Travogen Cream (Isoconazole) and Travocort Cream (Isoconazole, Diflurcortolone) in the Treatment of Patients With Local Skin Mycosis of Various Etiology and Localization
- Lead sponsor
- LEO Pharma
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- February 28, 2009
- Enrollment
- 900 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
skin mycoses